Clinical Trial Update: Prophylaxis of Gastrointestinal Infections With EcN [Phase 4]

View source ↗

Summary

An update on a Phase 4 trial evaluating Escherichia coli Nissle 1917 for prophylaxis of gastrointestinal infections in infants. The current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infantile Diarrhea

Drugs mentioned

• Mutaflor (Escherichia coli Nissle 1917)

Snippet

Sponsor: Hospital San Bartolome | Conditions: Infantile Diarrhea | Phase 4 | Status: UNKNOWN